Actavis, Inc. Note Agreements
2 Contracts & Agreements
- WATSON PHARMACEUTICALS, INC., as Issuer and Wells Fargo Bank, National Association, as Trustee THIRD SUPPLEMENTAL INDENTURE Dated as of October 2, 2012 to the Indenture dated as... (Filed With SEC on October 2, 2012)
- WATSON PHARMACEUTICALS, INC. $3,900,000,000 $1,200,000,000 1.875% Notes due 2017 $1,700,000,000 3.250% Notes due2022 $1,000,000,000 4.625% Notes due 2042 UNDERWRITING AGREEMENT... (Filed With SEC on October 2, 2012)